Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "patients"

2955 News Found

Zydus Medtech inks pact with Braile Biomedica  to commercialise TAVI technology
News | April 18, 2025

Zydus Medtech inks pact with Braile Biomedica to commercialise TAVI technology

Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets


Zynext Ventures invests in Feldan Therapeutics to drive innovation in intracellular drug delivery
News | April 17, 2025

Zynext Ventures invests in Feldan Therapeutics to drive innovation in intracellular drug delivery

Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities


AstraZeneca Pharma India surrenders marketing authorisation for Olaparib 100mg and 150mg
News | April 16, 2025

AstraZeneca Pharma India surrenders marketing authorisation for Olaparib 100mg and 150mg

The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons


Dr. Lal PathLabs becomes South Asia's first to launch advanced test for amyloidosis
Diagnostic Center | April 15, 2025

Dr. Lal PathLabs becomes South Asia's first to launch advanced test for amyloidosis

More than 40 types of Amyloid proteins are discovered till date


Biocon Biologics secures market entry date for Yesafili in US
News | April 15, 2025

Biocon Biologics secures market entry date for Yesafili in US

YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions


Neuberg Diagnostics and Magnum Imaging inaugurates diagnostics centre in Trichy
Healthcare | April 15, 2025

Neuberg Diagnostics and Magnum Imaging inaugurates diagnostics centre in Trichy

Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation


Zyuds Lifesciences receives USFDA approval for DMD treatment drug
Drug Approval | April 14, 2025

Zyuds Lifesciences receives USFDA approval for DMD treatment drug

Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older


Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US
News | April 14, 2025

Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US

Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities


Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
Drug Approval | April 14, 2025

Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg

The product will be launched in Q1FY26


Drager launches Atlan A100 anesthesia workstation in India
News | April 12, 2025

Drager launches Atlan A100 anesthesia workstation in India

The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments